JO
PMVP icon

John Overdeck’s PMV Pharmaceuticals PMVP Stock Holding History

John Overdeck’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62M Buy
1,954,136
+69,606
+4% +$89.3K ﹤0.01% 2758
2026
Q1 		$2.34M Buy
1,884,530
+1,178,469
+167% +$1.5M ﹤0.01% 2637
2025
Q4 		$883K Buy
706,061
+436,440
+162% +$585K ﹤0.01% 3007
2025
Q3 		$377K Sell
269,621
-21,834
-7% -$30.2K ﹤0.01% 3117
2025
Q2 		$309K Sell
291,455
-61,772
-17% -$60.6K ﹤0.01% 2782
2025
Q1 		$385K Sell
353,227
-153,759
-30% -$209K ﹤0.01% 2624
2024
Q4 		$766K Buy
506,986
+23,931
+5% +$37.9K ﹤0.01% 2331
2024
Q3 		$720K Buy
483,055
+94,747
+24% +$146K ﹤0.01% 2294
2024
Q2 		$629K Sell
388,308
-11,402
-3% -$20.6K ﹤0.01% 2250
2024
Q1 		$680K Buy
399,710
+121,009
+43% +$226K ﹤0.01% 2184
2023
Q4 		$864K Buy
278,701
+244,630
+718% +$647K ﹤0.01% 2162
2023
Q3 		$209K Sell
34,071
-25,944
-43% -$178K ﹤0.01% 2626
2023
Q2 		$376K Sell
60,015
-76,935
-56% -$403K ﹤0.01% 2441
2023
Q1 		$653K Buy
136,950
+122,950
+878% +$865K ﹤0.01% 2086
2022
Q4 		$122K Sell
14,000
-14,400
-51% -$153K ﹤0.01% 2482
2022
Q3 		$338K Buy
+28,400
New +$410K ﹤0.01% 1926
2022
Q2 		– Sell
-44,900
Closed -$935K – 2847
2022
Q1 		$935K Sell
44,900
-226,646
-83% -$4M ﹤0.01% 1732
2021
Q4 		$6.27M Buy
271,546
+257,046
+1,773% +$6.21M 0.01% 1063
2021
Q3 		$432K Buy
+14,500
New +$463K ﹤0.01% 3381

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

John Overdeck's PMVP Position: Q2 2026 in Review

John Overdeck increased its PMV Pharmaceuticals (PMVP) stake by 3.7% in Q2 2026, buying an estimated $89.3K and bringing the position to 1,954,136 shares worth $2.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2758.

John Overdeck first reported a position in PMVP in Q3 2021 and has held it in 19 quarters since. The position peaked at $6.27M in Q4 2021. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • John Overdeck held 1,954,136 shares of PMV Pharmaceuticals worth $2.62M as of Q2 2026.
  • John Overdeck bought 69,606 PMV Pharmaceuticals shares in Q2 2026, an estimated $89.3K.
  • PMV Pharmaceuticals made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2758 holding.
  • John Overdeck first reported a position in PMV Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • John Overdeck's PMV Pharmaceuticals position peaked at $6.27M in Q4 2021.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.